BioCentury | Apr 12, 2010
Company News

Mologen, Synvolux, Federal Ministry of Education and Research deal

...vaccine to treat and prevent HBV infection using Mologen's MIDGE DNA vectors against HBV and Synvolux's...
...portion. IP ownership resulting from the deal was not disclosed. Mologen AG (Xetra:MGN), Berlin, Germany Synvolux Therapeutics B.V....
BioCentury | Jan 8, 2007
Company News

Mologen, Onco Life Sciences Pvt. Ltd., Synvolux deal

...I/II testing to treat RCC this year. Separately, MGN received exclusive, worldwide rights to use Synvolux's...
...not disclosed. Mologen AG (FSE:MGN), Berlin, Germany Onco Life Sciences Pvt. Ltd. , Pune, India Synvolux Therapeutics B.V....
Items per page:
1 - 2 of 2
BioCentury | Apr 12, 2010
Company News

Mologen, Synvolux, Federal Ministry of Education and Research deal

...vaccine to treat and prevent HBV infection using Mologen's MIDGE DNA vectors against HBV and Synvolux's...
...portion. IP ownership resulting from the deal was not disclosed. Mologen AG (Xetra:MGN), Berlin, Germany Synvolux Therapeutics B.V....
BioCentury | Jan 8, 2007
Company News

Mologen, Onco Life Sciences Pvt. Ltd., Synvolux deal

...I/II testing to treat RCC this year. Separately, MGN received exclusive, worldwide rights to use Synvolux's...
...not disclosed. Mologen AG (FSE:MGN), Berlin, Germany Onco Life Sciences Pvt. Ltd. , Pune, India Synvolux Therapeutics B.V....
Items per page:
1 - 2 of 2